Focus:
Boehringer Ingelheim has formed an alliance with US-based PureTech Health to develop new drug candidates for a variety of targets...
Ensure your company's deals are accurately presented to thousands of potential clients by using our deals submission form.
Europe's pharma industry saw a drop of 27.3% in overall deal activity during Q4 2018, when compared to the last four-quarter average, according to GlobalData's deals database.
North America's pharma industry saw a rise of 1% in overall deal activity during Q4 2018, when compared to the last four-quarter average, according to GlobalData's deals database.
Europe's pharma industry saw a drop of 3.9% in deal activity during February 2019, when compared with the last 12-month average, according to GlobalData's deals database.
North America's pharma industry saw a drop of 15.7% in deal activity during February 2019, when compared with the last 12-month average, according to GlobalData's deals database.
The US pharma industry saw a drop of 16.7% in overall deal activity during February 2019, when compared with the last 12-month average, according to GlobalData's deals database.
The UK pharma industry saw a drop of 25% in overall deal activity during Q4 2018, when compared with the last four-quarter average, according to GlobalData's deals database.
China's pharma industry saw a rise of 16.7% in overall deal activity during Q4 2018, when compared with the last four-quarter average, according to GlobalData's deals database.
Total pharma industry venture financing deals in February 2019 worth $1.7bn were announced globally, according to GlobalData's deals database.
Total pharma industry M&A deals in February 2019 worth $28.83bn were announced globally, according to GlobalData's deals database.
Total pharma deals worth $21.11bn were announced during Q4 2018, according to GlobalData's deals database.
Boehringer Ingelheim has formed an alliance with US-based PureTech Health...
Pulmatrix and Cipla Technologies have signed a definitive agreement to...
Gilead Sciences has partnered with insitro, a data-driven drug discovery...
Catalent, a provider of biologic drug development and manufacturing services,...
UK-based Enesi Pharma has partnered with the US Biomedical Advanced...
DNAnexus and Sutter Health have partnered with the University of...
Bristol-Myers Squibb has secured shareholders’ approval for its $74bn acquisition...
Gene therapy company Asklepios BioPharmaceutical (AskBio) has received an investment...
Novartis unit Sandoz has entered an agreement to commercialise Japanese pharmaceutical...
Pfizer has partnered with patient-centred research firm Concerto HealthAI to...
Go Top
